DoctorColin Curtain

Lecturer in Pharmacy - Online Courses

Pharmacy

  • Lecturer in Pharmacy - Online Courses
    Pharmacy
  • +61 3 6226 1096 (Work)
  • School of Pharmacy and Pharmacology, Pharmacy, 3014 Pharmacy, Sandy Bay Campus, TAS

RESEARCH SUMMARy

Expertise

Colin has an interest in aged care, clinical pharmacy and pharmacy practice, particularly with a health informatics aspect. Specific interests include medications in older people and in the capacity of information technology to prevent, detect and resolve drug-related problems.
Research Themes

Colin's research aligns with the University's research theme of Better Health. Colin has an interest in aged care, clinical pharmacy and pharmacy practice, particularly with a health informatics aspect. Specific interests include medications in older people and in the capacity of information technology to prevent, detect and resolve drug-related problems.

FUNDED PROJECTS

  • GRANT
    From Reduction to Optimisation: Integrating an Alert System for Anticholinergic Medication in the Elderly
    1 Jan 2024 - 30 Sep 2026
    People funded by this grant:
    • Salahudeen M,
    • Peterson G,
    • Adamczewski B,
    • Wilson A,
    • Bayer G
    Project Total: $24,944; The safe and quality use of medicines is a new National Health Priority Area, with significant health consequences, particularly for older people. This innovative project will implement and evaluate a sticker alert system in the patients progress notes to optimise anticholinergic medication therapy to reduce the risk of adverse outcomes. The project also aims to modify the existing anticholinergic medications rating score (high=3, moderate=2, low=1) for the Australian context through a modified Delphi process. Funded by: Royal Hobart Hospital Research Foundation - Grant-Project ($24,944); University of Tasmania.
  • GRANT
    Preventing Adverse Drug Reactions in the Elderly
    1 Jan 2019 - 30 Jun 2023
    People funded by this grant:
    • Bereznicki L,
    • Curtain C,
    • Bereznicki B,
    • Cousins J,
    • Connolly M
    Project Total: $274,000; Based on our prospective adverse drug reaction (ADR) registry:1 * 15% of medical admissions to Tasmanian public hospitals in elderly patients were ADR-related, * 89% were preventable, * 17% patients had a repeat ADR within 12 months, and * One third of patients with repeat ADRs experienced the same ADR caused by the same medications. From this clinical registry, we developed and validated an ADR risk prediction score (PADR-EC).2 We hypothesise that ADR risk stratification during hospitalisation and communication of this risk, together with recommendations that target the specific risk factors identified, to GPs at discharge will reduce the risk of ADR-related hospitalisation. Design: A randomised controlled trial (RCT) at the Royal Hobart Hospital, the major public hospital in Tasmania. Population: Over 12-months, 1000 patients ≥65 years with unplanned admissions to medical wards will be recruited and randomly allocated to intervention or control groups. Intervention: A researcher will perform an ADR risk assessment using the PADR-EC Score,2 which is the sum of points assigned to 5 independent predictors of ADR-related hospitalisation. Based on the PADR-EC Score and the specific risk factors identified, recommendations to reduce the risk of ADRs will be determined. Recommendations will relate to: * post-discharge medication management services, * monitoring of specific parameters/medications, and * de-prescribing strategies. The PADR-EC Score and recommendations will be communicated to the patient and clinical team during hospitalisation, and the patient's GP, alongside the usual information, in the electronic discharge summary. Control: Usual hospital care, with GPs receiving the standard discharge summary. Follow up: All participants will be followed by the research team for 12-months to identify ADRs (including their management and outcome) and health services received. Outcomes: ADR-related hospitalisation (primary); ADRs requiring hospital treatment, change in therapy or specific treatment (secondary). The study will be powered to detect a 5% difference in the primary outcome Funded by: Hospitals Contribution Fund Research Foundation - HCF - Grant-Health Services Research Program ($274,000); University of Tasmania.
  • CONSULTANCY/CONTRACT RESEARCH
    Trial of Semi-Automation of Identification of Drug Name Similarity
    1 Jan 2017 - 31 Dec 2017
    People funded by this grant:
    • Curtain C,
    • Emmerton L,
    • Nguyen G
    Project Total: $9,456; A 2016 consultancy project by Lynne Emmerton, recommended trial of a semi-automated system to proactively identify drug name pairs that look alike and/or sound alike, and are therefore at risk of prescribing, dispensing or drug administration errors. Confusable drug name pairs can be prioritised for Tall Man lettering, whereby upper-case font is used to highlight the distinguishing letters of each drug name in the pair. The original Tall Man Lettering Standard identified confusable drug name pairs manually, using error reports and near-misses. With tens of thousands of drugs available, and dozens of new drugs approved or discontinued each year in Australia, automated name-pair screening and computation of name similarity scores is a logical progression. Funded by: Australian Commission on Safety and Quality in Health Care ($9,456); University of Tasmania.
  • GRANT
    Vitamin D and calcium supplementation amongst residents of aged care facilities in Australia: are guidelines being followed?
    1 Jan 2015 - 31 Mar 2016
    People funded by this grant:
    • Williams M,
    • Curtain C
    Project Total: $16,100; Funded by: University of Tasmania - Grant-Research Enhancement (REGS); University of Tasmania ($16,100).